Advaxis Announces First Patient Dosed in Brown University Sponsored Anal … – Wall Street Journal

Advaxis Announces First Patient Dosed in Brown University Sponsored Anal
Wall Street Journal
Advaxis, Inc., (OTCBB: ADXS) ("Advaxis" or the "Company"), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that the first patient has been dosed in a Phase 1/2 study of ADXS-HPV in 25 patients
Advaxis and FusionVax Sign a Memorandum of Understanding for the License MarketWatch (press release)

all 2 news articles »

View full post on hpv – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *